Patents

Intellectual property

Patent information

SPR’s extensive patent portfolio with over 200 issued and pending US and Foreign patents protects the SPR systems and methods of treating pain. Years of experience, trade secrets, proprietary methodology, software, firmware, manufacturing techniques, and other technologies have created the SPR systems that are designed to be reliable, easy to deploy and remove, and provide non-opioid, cost effective pain treatments.

Patents

The following U.S. patents listed below are applicable to the SPRINT electrical stimulation system for the treatment of pain and method of use:

7,120,499

7,571,002

8,086,318

7,797,058

D683,320

D665,085

9,339,647

8,700,177

8,079,865

8,231,402

8,357,006

8,616,913

7,996,092

8,463,383

10,981,005

11,883,660

9,827,419

11,878,164

10,632,309

11,806,533

10,625,075

9,555,245

11,116,971

8,965,516

9,884,189

10,426,959

11,420,057

8,954,153

10,307,585

11,027,123

11,771,891

9,895,530

9,855,427

9,248,289

9,616,229

10,076,663

9,707,394

10,857,361

10,722,715

11,344,726

11,612,746

8,788,048

8,788,046

8,788,047

8,886,337

9,381,343

9,827,412

10,166,384

10,869,999

11,944,809

11,311,727

10,668,285

11,235,146

11,103,697

11,135,437

11,745,011

11,878,176

11,541,235

11,806,300

11,540,973

11,413,450

11,896,820

D674,105

D658,304

D934,438

D1,021,113

D904,629

D1,000,619

D964,935

D901,447

D945,250

D884,165

11,742,106

 

 

Last Updated: January 24, 2025

To protect the intellectual property embodied in its patents, as well as to provide public notice of such, SPR applies a virtual patent marking to its patent protected products. A list of virtually marked patent protected products is provided here. The list identifies patents that cover and protect SPR products. SPR provides this list to give public notice of its patent rights in compliance with the U.S. Patent Act (35 U.S.C. § 287(a)). As such, this list represents SPR’s good faith effort to identify those patents that have at least one claim covering the applicable product. Errors, if any, are not the result of deceptive intent.